Patrik Brundin
Patrik Brundin (born December 26, 1961, in Malmö, Sweden) is a neuroscientist known for his research on Parkinson's disease (PD) and Huntington's disease. He is currently a Distinguished Scientist and serving as Therapeutic Area Leader for Movement Disorders at F. Hoffmann-La Roche, Pharmaceutical Research and Early Development (pRED).Brundin was educated at Lund University from 1980 to 1992, where he became a full professor in 2000. In 2012, he was appointed the Jay Van Andel Endowed Chair in Parkinson's Research at Van Andel Institute, Grand Rapids, Michigan. Before moving to F. Hoffmann-La Roche in 2022, Brundin held multiple roles at the institute such as the Deputy Chief Scientific Officer, the Director of the Center for Neurodegenerative Science and the Parkinson's Disease Center. Provided by Wikipedia
Showing 1 - 20 results of 45 for search 'Patrik Brundin', query time: 0.06s
Refine Results
-
1
-
2
Article Commentary: Cell Transplantation and Neuroscience by Paul R. Sanberg, Patrik Brundin
Published 1999-01-01
Article -
3
Editorial: Pathogenic templating proteins in Neurodegenerative Disease by Laura Volpicelli-Daley, Patrik Brundin
Published 2018-01-01
Article -
4
-
5
-
6
-
7
-
8
-
9
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases by Nolwen L. Rey, Daniel W. Wesson, Patrik Brundin
Published 2018-01-01
Article -
10
-
11
Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience by Simon R. W. Stott, Richard K. Wyse, Patrik Brundin
Published 2021-03-01
Article -
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20